Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition

The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial-mesenchymal transition in thymic carcinoma

(2019) Soichiro Funaki et al.   Cancer Medicine

Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers

(2018) KATSUO USUDA et al.   ANTICANCER RESEARCH

Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3

(2018) Bingxin Zheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review

(2018) Dinesh Kumar Chellappan et al.   BIOMEDICINE & PHARMACOTHERAPY

Expression of VEGF with tumor incidence, metastasis and prognosis in human gastric carcinoma

(2018) Dengxiang Liu et al.   Cancer Biomarkers

VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer

(2018) Ying Chen et al.   CELLULAR & MOLECULAR BIOLOGY LETTERS

Antiangiogenic therapy: Markers of response, “normalization” and resistance

(2018) Karima El Alaoui-Lasmaili et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Issues and promises of bevacizumab in prostate cancer treatment

(2018) Vittore Cereda et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

(2018) Marco B. Schaaf et al.   Cell Death & Disease

Correlation between ultrasonic features and expression levels of C-erbB-2, VEGF and nm23 in breast cancer

(2018) Min Nie et al.   Oncology Letters

Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma

(2018) Xin Gao et al.   CANCER JOURNAL

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors

(2018) Pedro Miguel Lacal et al.   PHARMACOLOGICAL RESEARCH

Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis

(2018) Li Sun et al.   Cell Death & Disease

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214

(2018) Chen Ying et al.   Cancer Biology & Medicine

The Role of PD-1 Checkpoint Inhibition in Gynecologic Malignancies

(2018) Christine Garcia et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms

(2018) Yun Xia et al.   INTERNATIONAL JOURNAL OF CANCER

Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer

(2018) Emmett V. Schmidt   Seminars in Immunopathology

Predictive biomarkers for tumor immune checkpoint blockade

(2018) Mengting Tong et al.   Cancer Management and Research

Epidemiology and treatment patterns of epithelial ovarian cancer

(2017) Philip Jessmon et al.   Expert Review of Anticancer Therapy

Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer

(2017) Vera Loizzi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer

(2017) Pau Riera et al.   PHARMACOGENOMICS JOURNAL

Predictors of responses to immune checkpoint blockade in advanced melanoma

(2017) N. Jacquelot et al.   Nature Communications

Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma

(2017) Hua Zhou et al.   NEOPLASIA

The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer

(2016) Tetsuro Ikeya et al.   BMC CANCER

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma

(2016) Kazuki Takada et al.   Journal of Thoracic Oncology

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway

(2016) Vassiliki A. Boussiotis   NEW ENGLAND JOURNAL OF MEDICINE

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

(2016) Joseph McLaughlin et al.   JAMA Oncology

Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research

(2015) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients

(2015) Katherine C. Fuh et al.   GYNECOLOGIC ONCOLOGY

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

(2014) Eric Pujade-Lauraine et al.   JOURNAL OF CLINICAL ONCOLOGY

Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients

(2014) Huidong Liu et al.   MICROVASCULAR RESEARCH

The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4

(2013) Hua Zhou et al.   ANGIOGENESIS

B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells

(2013) Sheng-Jia Shi et al.   PLoS One

Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression

(2012) Hua Zhou et al.   ANGIOGENESIS

The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma

(2012) Hua Zhou et al.   EXPERIMENTAL CELL RESEARCH

Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1α; and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer

(2012) Ying Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas

(2011) Jie Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Anti-VEGF Treatment-Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype

(2011) C. Carbone et al.   CLINICAL CANCER RESEARCH